Home » Topics » Disease categories and therapies » Immune

Immune
RSS

PDL to humanize Fujisawa antibody

Feb. 17, 2000

Bio-Technology General obtains first marketing approval worldwide for HBV vaccine

Feb. 15, 2000

AHP prepares new rapamycin derivatives

Feb. 14, 2000

New immunosuppressive agents derived from LK6-A

Feb. 14, 2000

ID Biomedical's GAS vaccine well tolerated in early clinical testing

Feb. 14, 2000

SmithKline Beecham and ImClone Systems to collaborate on meningitis vaccine

Feb. 11, 2000

Dynavax and Aventis Pasteur enter strategic collaboration to develop novel vaccines

Feb. 11, 2000

Immunomedics allowed patent for therapeutic vaccines

Feb. 10, 2000

FluMist provides unexpected protection against flu strain not covered by vaccine in children

Feb. 9, 2000

North American Vaccine reports Hib vaccine results to FDA advisory panel

Feb. 8, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...